Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Stopping over-medication of people with intellectual disability, Autism or both (STOMP) in England part 1 – history and background of STOMP

Stopping over-medication of people with intellectual disability, Autism or both (STOMP) in... The programme – Stopping the over-medication of people with an intellectual disability, Autism or Both (STOMP) is a three-year programme supported by NHS England. Concern about the overuse of antipsychotic drugs has been a constant theme since the 1970s. However, despite a multitude of guidelines the practice continues. The report into the events at Winterbourne View not only raised concerns about the overuse of antipsychotic drugs but of antidepressants and multiple psychotropic drug use. The purpose of this paper is twofold: Part 1 is to present the history and background to the use of psychotropic drugs in intellectual disabilities, autism or both; and Part 2 presents the progress with the STOMP programme.Design/methodology/approachThe review tracks the various concerns, guidelines and attempts to tackle the issue of over medication of people with intellectual disability autism or both.FindingsThe review identifies that despite the many studies and guidelines associated with the prescribing of psychotropic drugs for people with an intellectual disability, autism or both the practice is common. Programmes that minimise the use of psychotropic drugs involve a full use of the multidisciplinary team and an availability of alternative methods of managing challenging behaviours.Originality/valueSTOMP is part of an English national agenda – Transforming care. The English Government and leading organisations across the health and care system are committed to transforming care for people with intellectual disabilities, autism or both who have a mental illness or whose behaviour challenges services. This review identifies many studies, programmes and guidelines associated with psychotropic drug use for people with an intellectual disability, autism or both. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Mental Health and Intellectual Disabilities Emerald Publishing

Stopping over-medication of people with intellectual disability, Autism or both (STOMP) in England part 1 – history and background of STOMP

Download PDF
10 pages

Loading next page...
 
/lp/emerald-publishing/stopping-over-medication-of-people-with-intellectual-disability-autism-0xAiquI1bL
Publisher
Emerald Publishing
Copyright
© Emerald Publishing Limited
ISSN
2044-1282
DOI
10.1108/amhid-02-2018-0004
Publisher site
See Article on Publisher Site

Abstract

The programme – Stopping the over-medication of people with an intellectual disability, Autism or Both (STOMP) is a three-year programme supported by NHS England. Concern about the overuse of antipsychotic drugs has been a constant theme since the 1970s. However, despite a multitude of guidelines the practice continues. The report into the events at Winterbourne View not only raised concerns about the overuse of antipsychotic drugs but of antidepressants and multiple psychotropic drug use. The purpose of this paper is twofold: Part 1 is to present the history and background to the use of psychotropic drugs in intellectual disabilities, autism or both; and Part 2 presents the progress with the STOMP programme.Design/methodology/approachThe review tracks the various concerns, guidelines and attempts to tackle the issue of over medication of people with intellectual disability autism or both.FindingsThe review identifies that despite the many studies and guidelines associated with the prescribing of psychotropic drugs for people with an intellectual disability, autism or both the practice is common. Programmes that minimise the use of psychotropic drugs involve a full use of the multidisciplinary team and an availability of alternative methods of managing challenging behaviours.Originality/valueSTOMP is part of an English national agenda – Transforming care. The English Government and leading organisations across the health and care system are committed to transforming care for people with intellectual disabilities, autism or both who have a mental illness or whose behaviour challenges services. This review identifies many studies, programmes and guidelines associated with psychotropic drug use for people with an intellectual disability, autism or both.

Journal

Advances in Mental Health and Intellectual Disabilities – Emerald Publishing

Published: Feb 8, 2019

Keywords: Autism; Intellectual disability; Learning disability; Polypharmacy; Call to action methodology; Psychotropic drugs

References

  • Reducing antipsychotic medication in people with a learning disability
    Ahmed, Z.; Fraser, W.; Kerr, M.P.; Kiernan, C.; Emerson, E.; Robertson, J.; Felce, D.; Allen, D.; Baxter, H.; Thomas, J.
  • A study of prescribing for people with learning disabilities living in the community and in national health service care
    Branford, D.
  • A review of antipsychotic drugs prescribed for people with learning disability who live in Leicestershire
    Branford, D.
  • Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities
    Branford, D.
  • Stopping over-medication of people with an intellectual disability, Autism or both (STOMP) Part 2 – the story so far
    Branford, D.; Webster, A.; Shaw, C.; Gerrard, D.; Saleem, N.
  • Survey of medication for detained patients with a learning disability
  • Use of psychotropic medication in children and adolescents with autism spectrum disorders
    Coury, D.; Anagnostou, E.; Manning-Courtney, P.; Reynolds, A.; Cole, L.; McCoy, R.; Agnes Whitaker, A.; Perrin, J.M.
  • Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability
    De Kuijper, G.; Evenhuis, H.; Minderaa, R.B.; Hoekstra, P.J.
  • Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour
    Deb, S.; Unwin, G.; Deb, T.
  • Impact of interdisciplinary team review on psychotropic drug use with persons who have mental retardation
    Findholt, N.E.; Emmett, C.G.
  • Prescribing in a hospital for the mentally retarded
    Fischbacher, E.
  • Dementia & antipsychotic prescribing audit 2012 London
  • Winterbourne view hospital a serious case review by Margaret Flynn
  • A follow-up study of prescribing for people with learning disabilities previously in national health service care in Leicestershire, England
    Branford, D.
  • The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities
    Deb, S.; Sohanpal, S.; Soni, R.; Unwin, G.; Lenôtre, L.
  • International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities
    Deb, S.; Kwok, H.; Bertelli, M.; Salvador-Carulla, L.; Bradley, E.; Torr, J.; Barnhill, J.
  • Transforming care: a national response to Winterbourne view hospital – department of health review: final report
  • Learning disabilities census report – further analysis England
  • Stopping over-medication of people with a learning disability (STOMPLD) pledge
  • Winterbourne medicines programme: improving the use of medicines in people with learning disabilities
  • The management and support of children and young people on the autism spectrum (CG170)”
  • Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges
  • Mental health problems in people with learning disabilities: prevention, assessment and management
  • Prescribing of psychotropic drugs to people with learning disabilities and or Autism by general practitioners in England
  • Stopping overuse of medication in people with learning disability
  • Psychotropic drug prescribing for people with intellectual disabilities, mental health problems and/or behaviours that challenge: practice guidelines
  • Treatment of psychiatric and behavioural problems in mental retardation – expert consensus guideline series
    Rush, A.; Frances, A.
  • Mental illness, challenging behaviour and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
    Sheehan, R.; Hassiotis, A.; Walters, K.; Osborn, D.; Strydom, A.; Horsfall, L.
  • Psychotropic medication use and polypharmacy in children with Autism spectrum disorders
    Spencer, D.; Marshall, J.; Post, B.; Kulakodlu, M.; Newschaffer, C.; Dennen, T.; Azocar, F.; Jain, A.